Journal of Viral Hepatitis

Cover image for Vol. 18 Issue 7

July 2011

Volume 18, Issue 7

Pages 449–524, e167–e407

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Hepatitis B surface antigen monitoring and management of chronic hepatitis B (pages 449–457)

      M. J. Sonneveld, R. Zoutendijk and H. L. A. Janssen

      Version of Record online: 23 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01465.x

      • image
      • image
      • image
      • image
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease (pages 458–467)

      X. Hu, S. Ma, X. Huang, X. Jiang, X. Zhu, H. Gao, M. Xu, J. Sun, W. G. H. Abbott and J. Hou

      Version of Record online: 1 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01475.x

      • image
      • image
      • image
      • image
    2. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants (pages 468–473)

      A. E. Singh, S. S. Plitt, C. Osiowy, K. Surynicz, E. Kouadjo, J. Preiksaitis and B. Lee

      Version of Record online: 11 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01333.x

    3. Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting (pages 474–481)

      W. N. Southern, M.-L. Drainoni, B. D. Smith, C. L. Christiansen, D. McKee, A. L. Gifford, C. M. Weinbaum, D. Thompson, E. Koppelman, S. Maher and A. H. Litwin

      Version of Record online: 20 MAY 2010 | DOI: 10.1111/j.1365-2893.2010.01327.x

    4. Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis (pages 493–505)

      V. Di Martino, J. Crouzet, P. Hillon, T. Thévenot, A. Minello and E. Monnet

      Version of Record online: 27 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01476.x

      • image
      • image
      • image
    5. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort (pages 506–512)

      B. P. Linas, B. Wang, M. Smurzynski, E. Losina, R. J. Bosch, B. R. Schackman, J. Rong, P. E. Sax, R. P. Walensky, J. Schouten and K. A. Freedberg

      Version of Record online: 9 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01325.x

      • image
    6. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy (pages 513–517)

      H. Hofer, I. Aydin, S. Neumueller-Guber, C. Mueller, T.-M. Scherzer, K. Staufer, P. Steindl-Munda, F. Wrba and P. Ferenci

      Version of Record online: 21 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01340.x

      • image
      • image
    7. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider (pages 518–524)

      I. H. Bahcecioglu, C. Aygun, N. Gozel, O. K. Poyrazoglu, Y. Bulut and M. Yalniz

      Version of Record online: 9 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01329.x

      • image
      • image
    8. What factors determine the severity of hepatitis A-related acute liver failure? (pages e167–e174)

      V. Ajmera, G. Xia, G. Vaughan, J. C. Forbi, L. M. Ganova-Raeva, Y. Khudyakov, C. K. Opio, R. Taylor, R. Restrepo, S. Munoz, R. J. Fontana, W. M. Lee and the Acute Liver Failure Study Group

      Version of Record online: 8 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01410.x

      • image
    9. Adefovir serum levels do not differ between responders and nonresponders (pages e175–e178)

      K. Deterding, L. Naesens, M. Buti, H. Janssen, J. Kirschner, A. Guerrero, J. Reijnders, J. Neyts, F. Zoulim and H. Wedemeyer

      Version of Record online: 7 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01404.x

      • image
    10. Development of a protocol for the quantitative determination of HBeAg using the Elecsys® HBeAg immunoassay (pages e179–e183)

      K. Wursthorn, B. J. Zacher, J. Jaroszewicz, M. Darnedde, M. Manns and H. Wedemeyer

      Version of Record online: 30 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01419.x

      • image
      • image
      • image
      • image
    11. An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients (pages e184–e190)

      X. Zhang, S.-m. Lin, F. Ye, T.-y. Chen, M. Liu, Y.-r. Chen, S.-q. Zheng, Y.-r. Zhao and S.-l. Zhang

      Version of Record online: 13 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01423.x

      • image
      • image
      • image
      • image
    12. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels (pages e191–e199)

      T. Nakazawa, A. Shibuya, A. Takeuchi, Y. Shibata, H. Hidaka, Y. Okuwaki, J. Takada, Y. Tanaka, M. Watanabe, T. Minamino, K. Sakurai and W. Koizumi

      Version of Record online: 11 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01427.x

      • image
      • image
      • image
      • image
      • image
    13. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study (pages e200–e205)

      J. Fung, C.-L. Lai, D. K.-H. Wong, W.-K. Seto, I. Hung and M.-F. Yuen

      Version of Record online: 7 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01428.x

      • image
      • image
      • image
      • image
    14. Unawareness of HBV infection among inpatients in a Southern Italian hospital (pages e206–e211)

      A. M. Ippolito, G. A. Niro, R. Fontana, G. Lotti, D. Gioffreda, M. R. Valvano, A. Iacobellis, L. Di Mauro, T. Stroffolini and A. Andriulli

      Version of Record online: 19 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01432.x

      • image
    15. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B (pages e212–e216)

      S. Mirandola, D. Campagnolo, G. Bortoletto, L. Franceschini, M. Marcolongo and A. Alberti

      Version of Record online: 21 JAN 2011 | DOI: 10.1111/j.1365-2893.2011.01435.x

    16. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B (pages e217–e225)

      F. M. Sanai, A. Helmy, K. I. Bzeizi, M. A. Babatin, A. Al-Qahtani, H. A. Al-Ashgar, A. S. Al-Mdani, A. Al-Akwaa, S. Almutharea, M. Q. Khan, A. S. Alghamdi, T. Farah, W. Al-Hamoudi, M. Saadeh and A. A. Abdo

      Version of Record online: 1 MAR 2011 | DOI: 10.1111/j.1365-2893.2011.01437.x

      • image
      • image
      • image
      • image
    17. Correlation between promoter methylation of glutathione-S-tranferase P1 and oxidative stress in acute-on-chronic hepatitis B liver failure (pages e226–e231)

      T. Li, Q.-H. Meng, Z.-Q. Zou, Y.-C. Fan, B. Long, Y.-M. Guo, W. Hou, J. Zhao, J. Li, H.-W. Yu, Y.-K. Zhu and K. Wang

      Version of Record online: 15 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01438.x

      • image
      • image
    18. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992–2007 (pages e232–e241)

      H.-H. Thein, S. R. Walter, H. F. Gidding, J. Amin, M. G. Law, J. George and G. J. Dore

      Version of Record online: 17 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01440.x

      • image
      • image
      • image
      • image
    19. Circulating microRNAs in hepatitis B virus–infected patients (pages e242–e251)

      F. Ji, B. Yang, X. Peng, H. Ding, H. You and P. Tien

      Version of Record online: 7 MAR 2011 | DOI: 10.1111/j.1365-2893.2011.01443.x

      • image
      • image
      • image
      • image
      • image
      • image
    20. Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B (pages e252–e257)

      N.-P. Zhang, J. G. P. Reijnders, M. Perquin, B. E. Hansen and H. L. A. Janssen

      Version of Record online: 1 MAR 2011 | DOI: 10.1111/j.1365-2893.2011.01448.x

      • image
      • image
    21. Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment (pages e258–e262)

      M. F. Derbala, A. M. Amer, M. Almohanadi, A. John, A. Amin, A. John, M. Sharma, S. R. Alkaabi, N. Z. Al Dweik, F. Pasic, R. Yaqoob, M. T. Butt and F. M. Shebl

      Version of Record online: 25 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01403.x

    22. A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients (pages e270–e277)

      A. Lawson and on behalf of the Trent Hepatitis C Study Group

      Version of Record online: 7 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01406.x

      • image
    23. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus (pages e278–e283)

      M. Sánchez-Conde, M. L. Montes Ramírez, J. M. Bellón Cano, A. Caminoa, F. Álvarez Rodríguez, J. González Garcia, P. Miralles Martín, I. Bernardino de la Serna, J. C. López Bernardo de Quirós, J. R. Arribas López, J. Cosín Ochaíta, J. F. Pascual Pareja, E. Alvarez and J. B. Berenguer

      Version of Record online: 3 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01407.x

    24. Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test (pages e292–e297)

      T. Kanda, F. Imazeki, Y. Yonemitsu, S. Mikami, N. Takada, T. Nishino, M. Takashi, A. Tsubota, K. Kato, N. Sugiura, A. Tawada, S. Wu, T. Tanaka, S. Nakamoto, R. Mikata, M. Tada, T. Chiba, T. Kurihara, M. Arai, K. Fujiwara, F. Kanai and O. Yokosuka

      Version of Record online: 3 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01409.x

      • image
    25. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA (pages e298–e306)

      D.-G. Ahn, S.-B. Shim, J.-E. Moon, J.-H. Kim, S.-J. Kim and J.-W. Oh

      Version of Record online: 7 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01416.x

      • image
      • image
      • image
      • image
    26. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients (pages e307–e314)

      M.-A. Loko, F. Bani-Sadr, M. Winnock, K. Lacombe, P. Carrieri, D. Neau, P. Morlat, L. Serfaty, F. Dabis, D. Salmon and for the ANRS CO 13 HEPAVIH Study Group

      Version of Record online: 11 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01417.x

    27. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression (pages e315–e324)

      J.-C. Lee, C.-k. Tseng, S.-F. Wu, F.-R. Chang, C.-C. Chiu and Y.-C. Wu

      Version of Record online: 20 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01424.x

      • image
      • image
      • image
      • image
    28. IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1 (pages e325–e331)

      M. Lindh, M. Lagging, B. Arnholm, A. Eilard, S. Nilsson, G. Norkrans, J. Söderholm, T. Wahlberg, R. Wejstål, J. Westin and K. Hellstrand

      Version of Record online: 13 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01425.x

      • image
      • image
    29. Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians (pages e332–e340)

      J. Cox, L. Graves, E. Marks, C. Tremblay, R. Stephenson, A. Lambert-Lanning and M. Steben

      Version of Record online: 1 FEB 2011 | DOI: 10.1111/j.1365-2893.2010.01426.x

      • image
    30. Hepatitis C virus replication in Caucasian HIV controllers (pages e350–e357)

      E. Ruiz-Mateos, K. Machmach, M. C. Romero-Sanchez, S. Ferrando-Martinez, P. Viciana, M. Del Val, M. A. Muñoz-Fernandez, M. Genebat, M. Leal and on behalf of the Cohort of the Spanish AIDS Research Network (CoRIS)

      Version of Record online: 18 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01431.x

      • image
      • image
      • image
    31. Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt (pages e358–e365)

      N. Vignier, G. Esmat, A. E. Sharkawy, M. Hassany, P. Bonnard, E. Delarocque-Astagneau, M. Said, R. Raafat, M. El-Hoseiny, A. Fontanet, M. K. Mohamed and M. Vray

      Version of Record online: 24 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01433.x

      • image
      • image
      • image
    32. Acute hepatitis C infection lowers serum lipid levels (pages e366–e371)

      K. E. Corey, J. Mendez-Navarro, L. L. Barlow, V. Patwardhan, H. Zheng, A. Y. Kim, G. M. Lauer and R. T. Chung

      Version of Record online: 8 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01434.x

      • image
      • image
      • image
    33. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1 (pages e372–e380)

      S. Petta, V. Di Marco, R. Di Stefano, D. Cabibi, C. Cammà, G. Marchesini and A. Craxì

      Version of Record online: 22 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01439.x

      • image
      • image
    34. Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation (pages e381–e393)

      P. Tandon, K. Doucette, K. Fassbender, B. Vandermeer, T. Durec and D. M. Dryden

      Version of Record online: 24 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01445.x

      • image
      • image
    35. Pregnancy outcomes associated with viral hepatitis (pages e394–e398)

      K. L. B. Reddick, R. Jhaveri, M. Gandhi, A. H. James and G. K. Swamy

      Version of Record online: 8 FEB 2011 | DOI: 10.1111/j.1365-2893.2011.01436.x

SEARCH

SEARCH BY CITATION